ALK has obtained acceptance from the MHRA to extend the use of specific lot (batch) numbers of Jext® 150 mcg and Jext® 300 mcg auto-injectors, beyond the labelled expiry date by two months.

Anaphylaxis UK is deeply saddened to learn of the death of Robin Wynne Williams, a 45-year-old construction engineer who tragically died from anaphylaxis due to a severe food allergy. Senior coroner Kate Robertson has ended the inquest into Robin’s death

New research finds that measuring water loss through the skin during food challenges can predict anaphylaxis before symptoms appear, increasing patient comfort and safety.

Researches in the US have completed a trial examining the safety and efficacy of sublingual immunotherapy and found it has potential for long lasting effects and is most effective in young children.

The biopharmaceutical company DBV Technologies is due to begin two safety trials for Viaskin Peanut in two age groups, known as COMFORT Toddlers and COMFORT Children.

An employee who was sacked after taking five days off work to recover from a near-fatal allergic reaction has successfully sued his employer on the grounds of disability discrimination.

A community pharmacist in Co Down, Northern Ireland, has been celebrated as a local hero after treating a woman with adrenaline after a bee sting caused an anaphylactic reaction

Researchers based at Birmingham Heartlands Hospital are inviting health professionals to take part in The FAIR Study to benefit patients from a South Asian Background with food allergies.

A small study has shown that a cancer drug called acalabrutinib improves tolerance to peanuts in the short term, making it the first drug to achieve rapid-onset prevention of IgE-induced food reactivity.